These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2857668)

  • 1. Reversal of D- and A-cell insensitivity to glucose in alloxan-diabetic dogs by treatment with the artificial beta cell (Biostator).
    Hermansen K; Schmitz O; Orskov H
    Diabetes; 1985 Mar; 34(3):260-6. PubMed ID: 2857668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of a priming effect of glucose on A and D cell secretion in perfused pancreases from alloxan-diabetic rats: role of insulin and alloxan.
    Grill V; Efendić S
    Diabetologia; 1983 Jan; 24(1):47-51. PubMed ID: 6131006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
    Greenbaum CJ; Havel PJ; Taborsky GJ; Klaff LJ
    J Clin Invest; 1991 Sep; 88(3):767-73. PubMed ID: 1679440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in somatostatin to glucagon ratio in islets of alloxan-diabetic dogs: effect of insulin-induced euglycemia.
    Rastogi KS; Brubaker PL; Kawasaki A; Efendic S; Vranic M
    Can J Physiol Pharmacol; 1993 Jul; 71(7):512-7. PubMed ID: 7902197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes.
    Braaten JT; Faloona GR; Unger RH
    J Clin Invest; 1974 Apr; 53(4):1017-21. PubMed ID: 4592597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
    Grill V; Efendić S
    Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term of the artificial beta-cell (Biostator) on pancreatic glucagon response in insulin-dependent diabetic (IDDM).
    Ratzmann KP; Schneider U; Besch W; Heinke P
    Exp Clin Endocrinol; 1984 Jul; 84(1):91-8. PubMed ID: 6383851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective impairment of pancreatic A cell suppression by glucose during acute alloxan-induced insulinopenia: in vitro study on isolated perfused rat pancreas.
    Filipponi P; Gregorio F; Cristallini S; Ferrandina C; Nicoletti I; Santeusanio F
    Endocrinology; 1986 Jul; 119(1):408-15. PubMed ID: 3522213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin diabetes: a glucoreceptor dysfunction affecting D cells as well as B and A cells.
    Hermansen K; Orskov H; Christensen SE
    Diabetologia; 1979 Dec; 17(6):385-9. PubMed ID: 395006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic A- and D-cell response to arginine during acute alloxan-induced intra-islet insulinopenia.
    Gregorio F; Cristallini S; Carloni C; Gubbiotti G; Pippi R; Filipponi P
    Diabetes Res Clin Pract; 1988 Jan; 4(2):89-94. PubMed ID: 2893695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
    Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes.
    Starke A; Grundy S; McGarry JD; Unger RH
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1544-6. PubMed ID: 3883362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas.
    Goto Y; Seino Y; Taminato T; Inoue Y; Kadowaki S; Mori K; Imura H
    Endocrinology; 1978 May; 102(5):1496-500. PubMed ID: 369831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum.
    Honey RN; Schwarz JA; Mathe CJ; Weir GC
    Am J Physiol; 1980 Feb; 238(2):E150-6. PubMed ID: 6444782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.
    Yoshida T; Nakamura Y; Nakano K; Kondo M
    Diabetes; 1981 May; 30(5):430-4. PubMed ID: 6262169
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin, glucagon, and insulin secretion from perfused pancreas of BB rats.
    Ruggere MD; Patel YC
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E221-7. PubMed ID: 6147095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.